Breaking Down Clinical Characterization & Differentiation Strategies to Set Up ADC Development for Success in an Increasingly Busy Oncology Landscape
1:00 pm - Thursday 15th October 2026
With more and more ADCs entering the clinic, it has never been more important to optimize clinical characterization and development strategies to demonstrate differentiation and benefit oncology patients.
Attend this session to dive into ADC clinical development strategy from bioanalytical characterization to support clinical dosing, understanding mechanisms of ADC resistance, and contextualizing opportunities to maximize differentiation in crowded oncology indications.
Workshop Highlights Include:
- Laying out ADC bioanalytical characterization to support clinical pharmacology, dosing strategy and trial design in early ADC clinical development
- Contextualizing ADC clinical development in an increasingly busy oncology therapeutic landscape: What are the strategies to deliver clinical impact with the bar for success raised?
- Breaking down tumor target expression and ADC resistance mechanisms to optimize approaches to unlock clinical benefit across combination and sequencing approaches
